Where we came from and where we're going.

Our Story

Dose Insight was founded by an established team of physicists, engineers, and entrepreneurs. Throughout our decades working in medical device development, we have seen first-hand the risks posed by sterilization validation. By leveraging our proven expertise in developing high performance modeling software, we created Dose Insight to solve an unmet need in the medical device community.

Dose Insight is a spin-out company from Triple Ring Technologies, a co-development company who stands side-by-side with innovators and entrepreneurs to solve hard problems, launch breakthrough products, and create new businesses.

Management Team

Tobias Funk, Ph.D.
Co-founder and CEO

Tobias is an established business leader, currently serving as the VP of Technology Development at Triple Ring Technologies. He has a proven track record of developing radiation-based instrumentation and software products, several of which have successfully been brought to market. Tobias received his M.S. and Ph.D. from Freie Universitat Berlin, Germany. He has authored over 20 peer-reviewed publications and has over 10 granted and pending patents. He is a reviewer, an associate editor, and a member of the editorial board for various peer-reviewed journals.


Daniel Badali, Ph.D., P.Phys.
Co-founder and CTO

Daniel has over a decade of experience developing innovative radiation technology. As a Staff Scientist at Triple Ring Technologies, he lent his technical leadership to a number of medical device development projects. Daniel holds a B.Sc. from the University of Toronto and M.Sc. and Ph.D. degrees in Physics from the University of Hamburg, Germany for work he did at the Max Planck Institute for the Structure and Dynamics of Matter. He is a certified Professional Physicist from the Canadian Association of Physicists.


Advisory Board

Joe Heanue, Ph.D.
President and CEO, Triple Ring Technologies

Dr. Joe Heanue has significant leadership experience in device and instrumentation research & development within interdisciplinary environments. He previously served as Vice President of Engineering at NexRay and at Signature Bioscience. At NexRay, Joe led the development of a low-dose x-ray imaging system for interventional cardiology. At Signature, he headed a group that delivered prototype RF and microwave spectroscopy instruments to a major instrument partner; the first of these instruments was launched in 2005 by MDS Sciex. Joe's extensive research and development experience includes the analysis and design of complex systems, x-ray and gamma-ray detector development, low-noise analog electronics, data-acquisition systems, signal and image processing, high-speed data-processing architectures, and thin-films failure analysis. Joe holds patents for detector and image processing, spectroscopy, and a patent for medical system imaging architecture that is licensed to a major medical equipment manufacturer. He received a BS in Physics from the Massachusetts Institute of Technology and earned his Ph.D. in Electrical Engineering and Computer Science from the University of California at Berkeley. Joe was a postdoctoral researcher at Xerox PARC, and he has completed the Stanford University Executive Program for Growing Companies.

Greg Kovacs, M.D., Ph.D.
Chief Medical Officer, Triple Ring Technologies

Greg served as Chief Technology Officer of SRI International supporting a broad range of invention, application and technology transitions across all divisions. He received a BASc degree in electrical engineering from the University of British Columbia, an MS degree in bioengineering from the University of California, Berkeley, and a PhD in electrical engineering and an MD degree from Stanford University. Greg is a Professor Emeritus of Electrical Engineering at Stanford University with a courtesy appointment in the Department of Medicine. His research areas include biomedical instruments and sensors, cardiovascular physiology, in vitro models for stem cell tissue repair, and medical diagnostics. He has published more than 180 peer-reviewed papers, has written one textbook and has 66 issued patents. From 2008 through 2010 he was Director of the Microelectronics Technology Office at DARPA. He has been a long-standing member of the Defense Sciences Research Council (DARPA), and has served as Associate Chair, then Chairman. He also has extensive industry experience including co-founding several companies, including Cepheid (acquired by Danaher) and Physiowave. He was also the Chief Technology Advisor for Malibu IQ, a private equity fund commercializing the intellectual property of HRL (formerly Hughes Research Laboratories).


We are always looking for motivated people looking to join a growing, dynamic team. Please get in touch to inquire about any open positions.